Jim Cramer Recommends This Energy Stock, But Don't 'Bank It All' On Arcus
1. Jim Cramer recommended caution with Arcus Biosciences, Inc. RCUS. 2. Wells Fargo analyst downgraded RCUS price target from $26 to $25. 3. RCUS shares gained 4% recently, closing at $10.06. 4. Speculative investment in RCUS is deemed risky by Cramer. 5. Uranium Energy Corp. also discussed, but unrelated to RCUS.